Diffuse idiopathic skeletal hyperostosis in subjects with congestive heart failure undergoing cardiac rehabilitation:

Insights

Diffuse idiopathic skeletal hyperostosis (DISH) is common in heart failure patients, affecting nearly half of those studied. Age and body mass index are key predictors of DISH in this population.

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Diffuse idiopathic skeletal hyperostosis (DISH) is a systemic skeletal disease characterized by widespread calcification and ossification of ligaments and entheses.
  • Congestive heart failure (CHF) is a complex clinical syndrome with significant morbidity and mortality.
  • The association between DISH and cardiovascular risk factors, particularly in patients with CHF, warrants further investigation.

Purpose of the Study:

  • To determine the prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in patients diagnosed with congestive heart failure (CHF).
  • To explore the relationship between DISH and established vascular risk factors within this patient cohort.

Main Methods:

  • A population-based, cross-sectional study was conducted.
  • 584 consecutive patients admitted to a Rehabilitative Cardiology Unit were included.
  • Chi-square Automatic Interaction Detector (CHAID) decision tree analysis and logistic regression were employed to identify predictors.

Main Results:

  • The prevalence of DISH among CHF patients was 49.8%.
  • Age was a significant predictor of DISH (OR 1.034, p<0.001), with prevalence increasing in those aged 69 years and older (60.1%).
  • Body mass index (BMI) was also a predictor in younger patients (<69 years), with BMI >23.3 kg/m² showing over double the prevalence of DISH (43.2% vs 20%).

Conclusions:

  • Diffuse idiopathic skeletal hyperostosis is highly prevalent in patients with congestive heart failure.
  • Age and body mass index emerged as the most significant predictors for DISH in this population.
  • These findings highlight the importance of considering DISH in CHF patients and investigating potential shared pathophysiological mechanisms.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
246
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
601
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
299
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
797
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
367
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
301